Navigation Links
States Promoted Broader Coverage for Children in 2007, But Report That a Declining Economy Coupled With Lack of SCHIP Reauthorization and New Federal Rules Now Compromise Efforts to Reduce the Number of Uninsured
Date:1/28/2008

WASHINGTON, Jan. 28 /PRNewswire-USNewswire/ -- New reports released today by the Kaiser Family Foundation's Commission on Medicaid and the Uninsured (KCMU) describe aggressive efforts by states in the past year and a half to expand coverage to low-income children and their families, but the actions may be curtailed as a deteriorating economic climate and new limits on federal assistance take effect.

A downturn in the economy, the federal failure to reauthorize the State Children's Health Insurance Program (SCHIP) and new federal rules affecting Medicaid and SCHIP eligibility all suggest that the recent period of aggressive expansion of coverage by states may be over. This is the conclusion based on a series of new studies by the KCMU, including a 50-state survey of eligibility and enrollment rules in Medicaid and SCHIP for children and families, interviews with Medicaid directors in ten states representing all regions of the country, and recent studies of enrollment in Medicaid and SCHIP.

"State momentum to address the growing problem of the uninsured has run into a double whammy of a declining economy that is putting additional pressure on state budgets and funds for Medicaid and SCHIP and federal barriers to state expansions," said Diane Rowland, executive director of the Kaiser Family Foundation's Commission on Medicaid and the Uninsured. "In the last recession, federal fiscal relief was critical to states' ability to sustain Medicaid enrollment. Without additional federal assistance for Medicaid and SCHIP in this economic downturn, we are likely to see added growth in the uninsured," she added.

Today's release of the seventh annual 50-state survey of eligibility rules, enrollment and renewal procedures, and cost-sharing practices in Medicaid and SCHIP for children and families, shows that nearly two-thirds (32) of states expanded access to their Medicaid and SCHIP programs between July 2006 and January 2008. However, without the
'/>"/>

SOURCE Kaiser Family Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. United States Joins False Claims Act Cases Against Three New Jersey Hospitals
2. United States Gives $12 Million to Pediatric AIDS Foundation Initiative
3. Engineering chimeric polypeptides to illuminate cellular redox states
4. The prevalence and impact of arthritis and other rheumatic conditions in the United States
5. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
6. Many States Still Fall Short in Emergency Preparedness: Report
7. Pew Study Finds States Face $2.73 Trillion Bill for Retiree Benefits
8. Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
9. Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award
10. EPA Plan to Evade Required Cuts in Mercury Pollution Challenged in Court by States, Tribes, Health and Environmental Groups
11. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...lements can also trigger acute organ failure, stud...s) -- Antibiotics are the single largest class of ...injury (DILI), researchers say. , The condition...iver failure in the United States and is the most ..., DILI is caused by a wide range of prescription ...
(Date:12/1/2008)...ps up successful disaster relief campaign , ,...he American Red Cross is asking people across the ...lion in 30 days. This holiday season push will put...Red Cross Campaign for Disaster Relief. Already, t...s launch in September, and the Red Cross hopes to ...
(Date:12/1/2008)... Today, more than 740 c...ople die each day due to HIV/AIDS. , , D...d outreach to help people worldwide understand the...S Day 2008 is You Can Make a Difference and th...her to talk about HIV as well as helping dispel th...
(Date:12/1/2008)...wswire-FirstCall/ -- SpectraScience, Inc.,(OTC Bu...ice company, today,announced that it has been awa...tem for Tissue Diagnosis. , Jim Hitchin, Spectr...nt to,the Company,s optical biopsy technology bec...e surveillance, characterization, diagnosis and tr...
Breaking Medicine News(10 mins):Health News:Antibiotics Largest Cause of Drug-Induced Liver Damage 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 3Health News:In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia 2Health News:SpectraScience Awarded European Patent for Its Optical Biopsy System for Tissue Diagnosis 2
...ride, taken by millions of balding men, artificial...igen (PSA) test,// the standard screening test for...he study, involving 308 men ranging in age from 40...in the British medical journal The Lancet and is s...
...harmacology held its annual meeting at Nashville o... behavior researchers called for// the need to mov...ropic drugs to treat mental illness. The panel co...emics, industry and government. They held several ...
...r, explained how India’s legal stance on homosexua...ainst HIV/AIDS and is an// infringement of the hum... mainly to bring offenders to book, in cases deali...e is also fear that if the law is annulled, it may...
...pray-on condom which will be suitable for all men....ndom Consultancy, said "We're trying to develop th...size of penis. We're very serious." The team is p... ‘can’ to exactly fit a man's penis. It is designe...
Other Medicine News:Health News:Hair-Growth Drug Artificially Lowers Psa Levels in Prostate Cancer Screening 2Health News:Research In A New Direction To Develop Innovative Psychotropic Drugs 2Health News:Research In A New Direction To Develop Innovative Psychotropic Drugs 3
(Date:11/28/2008)...Nov. 28 Eli Lilly and Co...al New Drug Application (sNDA) from,the U.S. Food...loxetine HCl),for the management of chronic pain....irst half of 2009, adding data from a recently com...ain of the knee. , The decision does not af...
(Date:11/26/2008)... to 406 Subjects , , FRANKLIN, Mass., Nov. ... Bulletin Board: PLCSF) announced today that it ha...ug Administration (FDA) for its U.S. pivotal trial...Guard System(TM) and associated therapy in the pr... , The FDA also approved PLC,s request to ex...
(Date:11/25/2008)...CISCO, Calif., Nov. 25 Proteolix, ...f novel therapeutics that target,protein degradat...day,announced that data from two ongoing Phase 2 ...a will be presented at the upcoming 50th Annual Me.... Carfilzomib is the first in a new class,of spe...
(Date:11/25/2008).... 25 CardioVascular,Bio...ounced today that it has,dosed the first patient ...I,clinical trial to treat patients with severe co... the treatment of CORonary heart Disease) trial wi...-controlled doses in approximately 120,patients w...
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Circulating tumor cells can reveal genetic signature of dangerous lung cancers 23209 1Circulating tumor cells can reveal genetic signature of dangerous lung cancers 23209 2Circulating tumor cells can reveal genetic signature of dangerous lung cancers 23209 3Coalition Calls on MI Legislature to Abandon Blue Cross Legislation 23205 1Coalition Calls on MI Legislature to Abandon Blue Cross Legislation 23205 2SpectraCell Laboratories Now Measures Vitamin C 6365 1SpectraCell Laboratories Now Measures Vitamin C 6365 2Circulating Tumor Cells Reveal Insights Into Lung Cancers 23201 1Circulating Tumor Cells Reveal Insights Into Lung Cancers 23201 2Circulating Tumor Cells Reveal Insights Into Lung Cancers 23201 3
..., Calif.--(BUSINESS WIRE)--Mar 14, 2007 - Research...say they are puzzled by,findings from their new st...ously showed promise in treating a behavioral diso... a sustained benefit,for the patients who took it....ribed,antidepressant sold under the brand name Lex...
...N, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarmi...of CANCER (a peer-reviewed,journal of the American...taking the standard five-year regimen of the hormo...continue therapy early.(1), According to the autho...or issue that may negatively affect treatment effi...
Other Medicine Technology:Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: